Fannin Innovation Studio is actively seeking Therapeutics interns and has an Open House coming up on May 26th
Fannin primarily in-licenses promising, early-stage therapeutic and medical device technologies from leading academic investigators in the Texas Medical Center and on a national stage. Fannin develops and de-risks these technologies via preclinical work and engineering up through early clinical trials. Additionally, Fannin builds the business model and use case, resulting in strategic partnerships or acquisitions.
Our internship program provides hands-on operational experience in early-stage life science development. Fannin offers two tracks in our internship program: Therapeutics and Medical Devices. Our interns work closely with established and potential portfolio companies, experientially learning about biomedical commercialization. Interns might be tasked with assisting with due diligence, working on market analysis, assisting with product development, or researching and understanding key regulatory requirements. All interns work closely with the core Fannin team to ensure a beneficial and useful experience.
We have had many interns and Fellows complete our program, and we look forward to receiving interest from more of your members!
Questions? Contact Serena Miggins or Stephanie Vega
https://fannininnovation.com/careers/
- Google Deepmind Unveils AlphaFold 3 AI Model For Drug Discovery Breakthroughs
Google takes the wraps off its latest AlphaFold 3 AI model, bringing a powerful new tool to life sciences researchers. - AI in Drug Discovery Market Size And Global Industry Forecast| MarketsandMarkets – WICZ
"The prominent players in artificial intelligence (AI) in drug discovery market are NVIDIA Corporation (US), Exscientia (UK), BenevolentAI (UK), … - How Torsional Data Can Inspire Drug Design – CCDC
The importance of looking at torsional data to guide the drug design journey, and how this can be do. - How AI is paving a new way for drug discovery in the UK
Hugo Villanueva, biotech investor at Octopus Ventures, says the omnipresent role of AI in both the drug discovery and development market is already … - Google DeepMind unveils next-gen AI model for drug discovery – MSN
Google DeepMind has introduced the third iteration of its groundbreaking artificial intelligence model, AlphaFold, aimed at enhancing the …